一级做a爰片久久毛片16-一级做a爰片久久毛片苍井优-一级做a爰片久久毛片潮喷-一级做a爰片久久毛片美女-精品国产午夜肉伦伦影院-精品国产香蕉伊思人在线

您好!歡迎訪問上海起發(fā)實(shí)驗(yàn)試劑有限公司網(wǎng)站!
全國服務(wù)咨詢熱線:

15921799099

當(dāng)前位置:首頁 > 產(chǎn)品中心 > > 生化試劑 > Microbix特約總代理

Microbix特約總代理

簡要描述:Microbix代理,Microbix中國代理,Microbix上海代理,Microbix總代,Microbix
Microbix專業(yè)代理-上海起發(fā)實(shí)驗(yàn)試劑有限公司,具體產(chǎn)品信息歡迎電詢

  • 產(chǎn)品型號:
  • 廠商性質(zhì):經(jīng)銷商
  • 更新時(shí)間:2024-09-02
  • 訪  問  量:2320

詳細(xì)介紹

Microbix代理,Microbix中國代理,Microbix上海代理,Microbix總代,Microbix
Microbix專業(yè)代理-上海起發(fā)實(shí)驗(yàn)試劑有限公司,具體產(chǎn)品信息歡迎電詢

加拿大公司,提供的傳染病產(chǎn)品,如TORCH,衣原體,流感抗原。使用技術(shù)在biotherapeutic藥物,疫苗和傳染病診斷和生產(chǎn)urokinase、腺病毒、retroviral和其他抗原和抗體。
www.microbix。。com/

Microbix Biosystems Inc. develops biological products and technologies. The Company was founded in 1988 as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies including VIRUSMAX (Influenza Virus Yield Enhancement Technology), LumiSort? (Semen Sexing Technology) and the thrombolytic drug, Kinlytic? (Urokinase). Funded by income from the antigen business, the pipeline products take aim at large market opportunities. With Microbix’ core competencies in the Infectious Disease Antigen business, including cell culture, molecular biology, and a GMP quality system, the pipeline products build on Microbix’ strength. Additional funding for research and development, when required, is raised by way of equity and debt offerings.

The Company operates out of two facilities: the infectious disease antigen manufacturing facility located at 265 Watline Avenue, Mississauga, Ontario; and a leased facility at 115 Skyway Avenue, Toronto, wher administration offices are located.

LumiSort?

LumiSort? is next generation instrument based (cytometric) technology that will improve the yield and quality of sexed semen while increasing the speed of sex-sorting by an order of magnitude over methods used in the livestock industry today. It incorporates a novel and innovative instrument design to address fundamental problems with the existing commercial sex selection technology, while providing Microbix with a strong and well differentiated inlectual property advantage in the industry.

LumiSort? technology emerged from Microbix’ research focus in semen sexing initiated in 2005, a program founded to establish a deeper understanding of the biomolecular composition of sperm cells, and focused on the question of delivering high quality sexed semen.

Urokinase

Urokinase (previously marketed under the trade names Kinlytic?, and Abbokinase?) is a natural human protein that stimulates the human body’s blood clot-dissolving processes. Urokinase is an injectable drug and is approved in Canada and the U.S. for clinical use as a thrombolytic agent for the treatment of pulmonary embolism and coronary occlusion. The drug’s originator, Abbott Laboratories, also received approval to market Urokinase in Canada for treatment of pulmonary embolism and the clearance of blocked biomedical catheters.

In September 2008, Microbix acquired all of the assets relating to the approval and sale of Urokinase in the United States, including the New Drug Application (NDA 21-846) filed by Abbott Laboratories with the U.S. Food and Drug Administration (FDA). Microbix originally identified Urokinase as a product for the Company to develop in order to become established in the biological drug business in the U.S. The product, a protein derived from large scale tissue culture, is a good fit with Microbix core competencies in cell culture, process scale-up, and protein biochemistry.

Microbix intends to serve the Urokinase market through existing FDA and more recently Health Canada approvals, leveraging opinion leader relationships, and formulary listings US hospitals. The Company plans to utilize our established, approved raw materials banks and Microbix’ expertise in cell culture production to proceed with the validation of Microbix’ Urokinase production facility, which will serve existing and new markets. The company will pursue inlectual property for new indications, particularly in ophthalmology and oncology.

Microbix intends to re-introduce Urokinase together with a partner bringing the financial and market resources to complement Microbix’ technical and infrastructure capabilities for Urokinase manufacture.

Virology 

The Virology business develops, manufactures and distributes infectious disease antigens for the medical diagnostic and vaccine research industries. The Company has commercialized over 60 products derived from infectious pathogens cultured and processed at its facilities.

VIRUSMAX?

VIRUSMAX technology is a proprietary process for recovery of more virus from influenza virus-infected chick embryos (eggs) to enhance influenza vaccine production. Virus associated with granular and fibrous debris in the allantoic fluid can be disassociated from the debris and recovered, thereby increasing yield. These increases enhance the productivity of the influenza vaccine manufacturing processes and decrease the time required to produce vaccine in response to emergent viral strains.

Patents have been granted in the U.S., Canada, Europe, India, Italy, Australia, China, Argentina, Mexico and Japan.

Microbix signed its first agreement to establish a manufacturing joint venture agreement in China to build and manage a new flu vaccine manufacturing facility.

上海起發(fā)實(shí)驗(yàn)試劑有限公司

實(shí)驗(yàn)試劑一站式采購服務(wù)商
1:強(qiáng)大的進(jìn)口輻射能力,血清、抗體、耗材、大部分限制進(jìn)口品等。
2:產(chǎn)品種類齊全,經(jīng)營超過700多個(gè)品牌,基本涵蓋所有生物實(shí)驗(yàn)試劑耗材。
3:提供加急服務(wù),貨品一般1-2周到貨。
4:富有競爭力的價(jià)格優(yōu)勢,絕大部分價(jià)格有優(yōu)勢。
5:多年積累良好的信譽(yù),大部分客戶提供貨到付款服務(wù)??蛻舭ㄇ迦A、北大、交大、復(fù)旦、中山等100多所高校,ROCHE,阿斯利康、國藥、fisher等藥企。
6:我們還是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等幾十家國外公司授權(quán)代理。
7:我們還是invitrogen,qiagen,Microbixam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發(fā),歡迎合作。

產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
上海起發(fā)實(shí)驗(yàn)試劑有限公司
地址:上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實(shí)驗(yàn)試劑有限公司
郵箱:xs1@78bio.com
傳真:021-50724961
關(guān)注我們
歡迎您關(guān)注我們的微信公眾號了解更多信息:
歡迎您關(guān)注我們的微信公眾號
了解更多信息
主站蜘蛛池模板: 国产青草亚洲香蕉精品久久 | 欧美深夜在线 | 亚洲一区二区三区久久久久 | 亚洲成在线 | 日本午夜大片a在线观看 | 国产三级做爰高清视频a | 一级在线观看视频 | 成人αv在线视频高清 | 波多野结衣高清videossex | 国产美女亚洲精品久久久毛片 | 99毛片 | 亚洲欧美色综合自拍 | 亚洲国产综合视频 | 伊人影院在线观看 | 亚洲天堂视频在线播放 | 亚洲免费在线观看视频 | 免费一级毛片在线视频观看 | 亚洲精品第一页中文字幕 | 在线观看免费精品国自产 | 24小时免费观看www日本 | 亚洲自拍图片区 | 国产成人一区二区三区视频免费 | 免费午夜不卡毛片 | 一二三四日本手机高清视频 | 欧美成人三级伦在线观看 | 一区二区三区鲁丝不卡麻豆 | 国产一级一片免费播放视频 | 91丨九色丨首页在线观看 | 欧美高清18 | 日韩亚洲一区二区三区 | 国产福利一区二区三区视频在线 | 国产免费v片在线看 | xxxx另类| 亚洲欧美专区精品久久 | 免费观看性行为的视频网站 | 高清日本一级特黄aa大片 | 伊人久久大香线焦在观看 | 中文字幕丰满乱码 | 国产无卡一级毛片aaa | 国内久久精品 | 久久男人精品 |